fentanyl has been researched along with B16 Melanoma in 2 studies
Fentanyl: A potent narcotic analgesic, abuse of which leads to habituation or addiction. It is primarily a mu-opioid agonist. Fentanyl is also used as an adjunct to general anesthetics, and as an anesthetic for induction and maintenance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1078)
fentanyl : A monocarboxylic acid amide resulting from the formal condensation of the aryl amino group of N-phenyl-1-(2-phenylethyl)piperidin-4-amine with propanoic acid.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Baamonde, A | 1 |
Menéndez, L | 1 |
González-Rodríguez, S | 1 |
Lastra, A | 1 |
Seitz, V | 1 |
Stein, C | 1 |
Machelska, H | 1 |
Andoh, T | 1 |
Shinohara, A | 1 |
Kuraishi, Y | 1 |
2 other studies available for fentanyl and B16 Melanoma
Article | Year |
---|---|
A low pKa ligand inhibits cancer-associated pain in mice by activating peripheral mu-opioid receptors.
Topics: Analgesics, Opioid; Animals; Bone Neoplasms; Cancer Pain; Cell Line, Tumor; Fentanyl; Hydrogen-Ion C | 2020 |
Inhibitory effect of fentanyl citrate on the release of endothlin-1 induced by bradykinin in melanoma cells.
Topics: Analgesics, Opioid; Animals; Bradykinin; Dose-Response Relationship, Drug; Endothelin-1; Fentanyl; M | 2017 |